A competitive ELISA for the quantitative determination of the novel anti-HIV drug candidate CIGB-210 in biological fluids-Reference-Cited by-同舟云学术

A competitive ELISA for the quantitative determination of the novel anti-HIV drug candidate CIGB-210 in biological fluids

Published:2018-11-29 Issue:2 Volume:40 Page:193-213
ISSN:1532-1819
Container-title:Journal of Immunoassay and Immunochemistry
language:en
Short-container-title:Journal of Immunoassay and Immunochemistry

Author:

Duarte Carlos A.¹^ORCID,Chávez Sheila¹,Masforrol Yordanka²,Puertas Samy³,Paneque Taimí¹,Ramirez Anna C.¹,Casillas Dionne¹,Puente Pedro³,Garay Hilda²,Fernández-Ortega Celia¹

Affiliation:

1. Pharmaceutical Departments, Centro de Ingeniería Genética y Biotecnología, La Habana, Cuba

2. Physical-Chemistry Departments, Centro de Ingeniería Genética y Biotecnología, La Habana, Cuba

3. Animal Research Departments, Centro de Ingeniería Genética y Biotecnología, La Habana, Cuba

Publisher

Informa UK Limited

Subject

Medical Laboratory Technology,Clinical Biochemistry,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/15321819.2018.1547975

Reference28 articles.

1. UNAIDS. (2018) Unaids Data 2018, UNAIDS, http://www.unaids.org/.

2. HIV Therapy—The State of ART

3. Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?

4. Global burden of transmitted HIV drug resistance and HIV-exposure categories

5. Host proteins involved in HIV infection: New therapeutic targets

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stability in human serum and plasma of the HIV peptide drug candidate CIGB‐210 and improved variants;Biotechnology and Applied Biochemistry;2024-09